(Q30400768)

21 June 2017

title

Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination (English)

1 reference

21 June 2017

0 references

Annalisa Capuano

5

0 references

author name string

Elisabetta Parretta

1

1 reference

21 June 2017

Benedetta Ianniello

2

1 reference

21 June 2017

Fernanda Ferrazin

3

1 reference

21 June 2017

Francesco Rossi

4

1 reference

21 June 2017

language of work or name

English

0 references

publication date

12 March 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

20

1 reference

21 June 2017

page(s)

3708-3713

1 reference

The medical dictionary for regulatory activities (MedDRA).

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

The importance of detailed diagnostic assessment in a case of partial situs inversus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Evaluating the safety of new vaccines: summary of a workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

What should an ideal vaccine postlicensure safety system be?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Methods for causality assessment of adverse drug reactions: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Safety Monitoring of a New Pentavalent Vaccine in the Expanded Programme on Immunisation in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Influenza vaccination in pregnancy: current evidence and selected national policies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Safety of influenza vaccination during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

The public's response to the 2009 H1N1 influenza pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.097

10.1016/J.VACCINE.2011.02.097

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference